Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $298.3700 (0.06%) ($295.7800 - $299.6900) on Tue. Jul. 16, 2019. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.01% (three month average) | | RSI | 40 | | Latest Price | $298.3700(0.06%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.6% a day on average for past five trading days. | | Weekly Trend | REGN declines -2.6% a week on average for past two weeks. | | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(58%) XLV(47%) IVW(41%) IWF(40%) QQQ(40%) | | Factors Impacting REGN price | REGN will decline at least -1.005% in a week (0% probabilities).
VIXM(-25%) VXX(-11%) IFRA(-7%) TLT(-6%) TIP(-1%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.005% (StdDev 2.01%) | | Hourly BBV | 0 () | | Intraday Trend | -0.3% | | | | | |
|
| Resistance Level | $307.81 | | 5 Day Moving Average | $296.48(0.64%) | | 10 Day Moving Average | $303.01(-1.53%) | | 20 Day Moving Average | $307.81(-3.07%) | | To recent high | -18.9% | | To recent low | 2.2% | | Market Cap | $31.636b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |